Prognostically relevant gene signatures of high-grade serous ovarian carcinoma. - Wikidata - wikimedia - TriplyDB

Prognostically relevant gene signatures of high-grade serous ovarian carcinoma.

Prognostically relevant gene signatures of high-grade serous ovarian carcinoma.

http://www.wikidata.org/entity/Q36497294

about

Genetic and epigenetic heterogeneity of epithelial ovarian cancer and the clinical implications for molecular targeted therapy Targeting Stromal-Cancer Cell Crosstalk Networks in Ovarian Cancer Treatment Stroma-associated master regulators of molecular subtypes predict patient prognosis in ovarian cancer.Treatment options in recurrent ovarian cancer: latest evidence and clinical potential.Molecular Characterization of Epithelial Ovarian Cancer: Implications for Diagnosis and Treatment Unique pattern of component gene disruption in the NRF2 inhibitor KEAP1/CUL3/RBX1 E3-ubiquitin ligase complex in serous ovarian cancer MAP3K8/TPL-2/COT is a potential predictive marker for MEK inhibitor treatment in high-grade serous ovarian carcinomas Ovarian cancer cell line panel (OCCP): clinical importance of in vitro morphological subtypes Molecular integrative clustering of Asian gastric cell lines revealed two distinct chemosensitivity clusters Dimension reduction techniques for the integrative analysis of multi-omics data Inferring tumour purity and stromal and immune cell admixture from expression data Más-o-menos: a simple sign averaging method for discrimination in genomic data analysis.A non-negative matrix factorization method for detecting modules in heterogeneous omics multi-modal data.Novel Monte Carlo approach quantifies data assemblage utility and reveals power of integrating molecular and clinical information for cancer prognosis Comparison of the Prognostic Utility of the Diverse Molecular Data among lncRNA, DNA Methylation, microRNA, and mRNA across Five Human Cancers.Medoidshift clustering applied to genomic bulk tumor data.NADPH oxidases: a perspective on reactive oxygen species production in tumor biology Long noncoding RNA expression signature to predict platinum-based chemotherapeutic sensitivity of ovarian cancer patients.A multivariate approach to the integration of multi-omics datasets NID1, a new regulator of EMT required for metastasis and chemoresistance of ovarian cancer cells Methylome analysis of extreme chemoresponsive patients identifies novel markers of platinum sensitivity in high-grade serous ovarian cancer.Epithelial-to-Mesenchymal Transition in the Female Reproductive Tract: From Normal Functioning to Disease Pathology.Differential antigen expression profile predicts immunoreactive subset of advanced ovarian cancers Single Gene Prognostic Biomarkers in Ovarian Cancer: A Meta-Analysis.Association between targeted somatic mutation (TSM) signatures and HGS-OvCa progression Combined image and genomic analysis of high-grade serous ovarian cancer reveals PTEN loss as a common driver event and prognostic classifier Prognostic and therapeutic relevance of molecular subtypes in high-grade serous ovarian cancer.Sox2 gene amplification significantly impacts overall survival in serous epithelial ovarian cancer Epithelial-mesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patients.Human monocytes in the presence of interferons alpha2a and gamma are potent killers of serous ovarian cancer cell lines in combination with paclitaxel and carboplatin Microarray enriched gene rank Comparison of gene expression patterns across 12 tumor types identifies a cancer supercluster characterized by TP53 mutations and cell cycle defects A phase II evaluation of pazopanib in the treatment of recurrent or persistent carcinosarcoma of the uterus: a gynecologic oncology group study Prediction of resistance to chemotherapy in ovarian cancer: a systematic review.Association between morphologic CT imaging traits and prognostically relevant gene signatures in women with high-grade serous ovarian cancer: a hypothesis-generating study.Systematic transcriptome analysis reveals tumor-specific isoforms for ovarian cancer diagnosis and therapy Characterization of twenty-five ovarian tumour cell lines that phenocopy primary tumours.In vivo tumor growth of high-grade serous ovarian cancer cell lines Vascular endothelial growth factor A as predictive marker for mTOR inhibition in relapsing high-grade serous ovarian cancer Big data and computational biology strategy for personalized prognosis.

P2860

Q26769604-F8CC1477-E1D5-4B0D-B154-AD22A9869A60 Q26769963-E6819433-8BE3-4EAF-A9ED-5A66F351677A Q27307642-25CEDB2D-E222-42BF-AB65-D3D5BA419F34 Q27692699-E5FCAFC5-46FF-4165-8FE9-26B668C94961 Q28066904-C6E955D0-CA35-4881-AD54-B459A299EF58 Q28391727-7DD0DA01-7F51-407C-AEFB-58C9BA3721DD Q28393224-09C10E4C-97CD-40C2-B657-12CE444CDCF2 Q28543021-73FA65CE-B7DB-4953-9372-998116B57AA4 Q28544116-154146DD-2C50-4343-8B90-C65679E5C6B1 Q28596239-B0CA9B34-6F65-4B7B-997C-88A234839341 Q30674996-A57CA02E-139F-4E2F-A1BE-176E95A32354 Q30838620-98E827BB-E1B9-4D96-9962-DD0442406A26 Q30993887-F6808BE0-DD49-425B-B882-28039B502BD2 Q31011575-D358B362-70D4-4F25-AC9B-0FA5E797FF23 Q31028108-64D7816D-E5E9-4FC6-A922-89C715EE7EFB Q31040446-8DC06B52-E04B-4852-8DCF-FB53DE2DC0CF Q33632660-12E199F3-E71D-43DA-A310-DA46AE25FC45 Q33671544-9172EE15-25C3-4C51-86B2-EC7BD19BD7BA Q33739977-310ED8E5-752F-4EE1-A2C6-9252C6A4F8FF Q33779379-863CE3D1-B2AC-4C84-AC40-96EB681B7923 Q33827681-26E7E785-EF86-48DD-8C0C-3638633DB10B Q33872622-D86692DE-60AD-42A3-97DA-74541708DB05 Q34472941-CE021902-B3D1-4EED-AD11-76F4C992FAEC Q34514528-67B69801-6137-402A-B7EC-563C06C43DFA Q34536160-E1CEFB81-220E-43C3-970C-BA4A9F6337AC Q34720998-129C2A78-A403-4431-809E-5EDB6AE69084 Q34736974-B161F916-6DCB-4ACA-908F-5E188835771A Q34766184-0FF22A56-BA15-45B4-B566-22020928A947 Q34880376-8960080A-87EE-4E4E-A08E-CCDD83B6A11B Q34920079-3F7E833B-A94D-4091-9668-51B637A6910A Q35008782-F645148A-6953-4B4B-A96A-11924E1A063E Q35050202-95E021A7-D094-490F-A039-82EAD34F365A Q35180428-5EB51981-CAA3-4C2F-97B7-BC11DB695DB9 Q35212386-1FF12E99-95BB-4D72-8096-6F14C82A119E Q35683375-AD3C0F2D-54ED-4D21-9214-8B3388CB5311 Q35740435-9F1319F2-9662-4086-95BE-D6E246A7AA55 Q35759295-CB3AA063-3DB0-4BCC-A3DA-1D921FC93D74 Q35927115-C86D617F-1604-4023-BBD8-014768B501FE Q35992948-F3B60A8C-CC86-4AA9-B77D-103B044ACF19 Q36031260-EC5B0A31-A775-480B-8B70-C1991205546B

P2860

Prognostically relevant gene signatures of high-grade serous ovarian carcinoma.

http://www.wikidata.org/entity/Q36497294

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Prognostically relevant gene signatures of high-grade serous ovarian carcinoma.

@ast

Prognostically relevant gene signatures of high-grade serous ovarian carcinoma.

@en

type

label

Prognostically relevant gene signatures of high-grade serous ovarian carcinoma.

@ast

Prognostically relevant gene signatures of high-grade serous ovarian carcinoma.

@en

altLabel

Prognostically relevant gene signatures of high-grade serous ovarian carcinoma

@en

prefLabel

Prognostically relevant gene signatures of high-grade serous ovarian carcinoma.

@ast

Prognostically relevant gene signatures of high-grade serous ovarian carcinoma.

@en

P1433

Q36497294-73D2E9C2-D204-48F5-911E-95CBB9664906

P1476

Q36497294-DED5FE76-939E-4E17-A6FF-6E7E943B5B5A

P2093

Q36497294-00581223-8621-47BF-8AE1-4B04AEF622F2

Q36497294-1260F5F5-96CD-43BE-B61C-25782FDEB674

Q36497294-23422885-9C78-429A-A219-100F392AD76B

Q36497294-24C71688-FBC5-4C80-A837-8C48A1BA0FFA

Q36497294-25DC95FC-7958-45F0-84D4-BA8C754E762B

Q36497294-3DF1C6BB-A6BF-48C6-9D1D-BDB1756B815A

Q36497294-4868859A-2EFA-443E-9655-8FFEE68930E9

Q36497294-4E3F748E-B4BA-48C1-A9D3-2C4F358AE30C

Q36497294-554DDA10-D275-4942-9278-A37BC22A1758

Q36497294-5A6D4592-E625-4081-BFF3-8132CAF51027

P2860

Q36497294-0542035E-75CE-459C-87A0-5B25900770CF

Q36497294-0B2673C1-AFB8-482D-A48F-01E9B61E90D9

Q36497294-0F029216-0BA6-4B7D-89AA-F19D9F34A568

Q36497294-10D62444-4509-479D-9A0F-9CA0F9E99580

Q36497294-13F42C05-8B04-4DA0-AAF2-FE925C5E188E

Q36497294-164CE026-50D3-426F-901C-7B52BFCD598C

Q36497294-1DDF788C-3096-4786-86AA-92868B9042DA

Q36497294-2187721D-E5E7-403D-B4D8-B000905B49EE

Q36497294-27CF0276-B8D2-4E62-901D-E6D5531326CC

Q36497294-35B4D750-5582-46F3-BC57-28397EE59AB9

P304

Q36497294-0794AAC2-618F-4AD0-A2D2-79C7513F6168

P31

Q36497294-3B497FF4-1542-4F51-A4C8-123606F84551

P356

Q36497294-9EAD8E04-2FE4-4626-9064-FB93ED98BE07

P407

Q36497294-D8F35AC9-39C7-463F-BEA4-ECE434F5EABB

P433

Q36497294-C3FDC8F2-106A-4043-8CC4-2BAED07384AE

P478

Q36497294-191EE661-5933-4FEE-ABBB-D7C38B278EC1

P50

Q36497294-0ECABAC0-AF8E-4852-A3BB-54E394CCF4B5

Q36497294-1839459E-B8EA-4EC3-9499-DE3780E890EC

Q36497294-1E8362B8-5297-4664-AFCD-A895A566F002

Q36497294-2323B69B-2157-46BF-9377-806439DAF8CD

Q36497294-49428D07-5B8C-4E36-AED7-2D3BC25206A2

Q36497294-63D30963-70BD-46AD-991E-65760DA414DC

Q36497294-657D8E2F-8FC8-4D39-9E54-EEC654CF3439

Q36497294-67C51212-900F-471F-9D9D-1BFA88B1345E

Q36497294-772AF413-9F27-4C82-AD5E-BF5A7822353A

Q36497294-7F9BC43E-FCE8-48BF-92DE-CA5ABF6766B3

P577

Q36497294-D6D223CD-5D57-4776-BCF2-5EBA7CDE4F80

P698

Q36497294-A65B6229-1304-4AC0-ACD1-5C9EC156B325

P932

Q36497294-D50E915B-385C-491F-9D91-C84F8B7DCD77

P356

P1433

Journal of Clinical Investigation

P1476

Prognostically relevant gene signatures of high-grade serous ovarian carcinoma.

@en

P2093

Ari Kahn

http://www.w3.org/2001/XMLSchema#string

Chad J Creighton

http://www.w3.org/2001/XMLSchema#string

Dariush Etemadmoghadam

http://www.w3.org/2001/XMLSchema#string

David Huntsman

http://www.w3.org/2001/XMLSchema#string

Diana Hubbard

http://www.w3.org/2001/XMLSchema#string

Douglas A Levine

http://www.w3.org/2001/XMLSchema#string

Hailei Zhang

http://www.w3.org/2001/XMLSchema#string

Ji-Yeon Yang

http://www.w3.org/2001/XMLSchema#string

Joe W Gray

http://www.w3.org/2001/XMLSchema#string

John N Weinstein

http://www.w3.org/2001/XMLSchema#string

P2860

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Significance analysis of microarrays applied to the ionizing radiation response

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers.

Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer.

Integrated genomic analyses of ovarian carcinoma

Cancer statistics, 2010

A gene-expression signature as a predictor of survival in breast cancer

Exploration, normalization, and summaries of high density oligonucleotide array probe level data

P304

517-525

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI65833

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

123

http://www.w3.org/2001/XMLSchema#string

P50

Jill P. Mesirov

Kristian Cibulskis

Robert A Soslow

P577

2012-12-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23257362

http://www.w3.org/2001/XMLSchema#string

P932

3533304

http://www.w3.org/2001/XMLSchema#string